Collectins such as surfactant proteins SP-A, SP-D, and mannan-binding lectin (MBL), as well as complement protein C1q are evolutionarily conserved innate immune molecules. They are known to opsonize a range of microbial pathogens (bacteria, fungi, virus, and parasites) and trigger effector clearance mechanisms involving phagocytosis and/or complement activation.
Introduction
The innate immune system is activated by receptors that recognize pathogen-associated molecular patterns (PAMPs) and bring about inflammatory responses, thus acting as immunomodulators (Janeway and Medzhitov, 2002) . These receptors have the ability to distinguish self from non-self molecules by recognizing the specific orientation of hydroxyl groups of hexoses (mannose, glucose, fructose and N-acetyl-D-glucosamine) and charge patterns, which are present on the surface of microbes (Medzhitov, 2007) . This binding promotes clearance of pathogens via neutralisation, agglutination, and/or phagocytosis (Kawai and Akira, 2010) .
Collectins belong to a family of evolutionarily conserved mammalian pattern recognition molecules that are characterized by calcium-dependent (C-type lectin) carbohydrate binding domain (Epstein et al., 1996) . Its members include surfactant protein A and D (SP-A and SP-D), mannose binding lectin (MBL), scavenger receptor collectin placenta-1 (CL-P1), collectin liver-1 (CL-L1), collectin kidney-1 (CL-K1), conglutinin, collectin of 43 kDa (CL-43), and collectin of 46 kDa (CL-46) (Kishore et al., 2006) . SP-A, SP-D and MBL are soluble oligomeric proteins. The structural organization of SP-A, SP-D and MBL includes four distinct regions: a short cysteine containing N-terminal region with disulphide bonds, a proline rich triple-helical collagen region with Gly-X-Y repeats, a hydrophobic α-helical coiled coil neck region, and a C-terminal lectin /carbohydrate recognition domain (CRD) region (Kishore et al., 2006) . The collagen domain is known to have receptors on various immune cells including calreticulin-CD91 receptor complex (Gardai et al, 2003) . Humans contain two highly similar SP-A genes, SPA-1 (SFTPA-1) with 5 exons and SP-A2 (SFTPA-2) with 6 exons (Katyal et al., 1992; McCormick et al., 1994) . SP-A is composed of 650 kDa, hexameric structure of six trimers.
Its collagen domain with 23 Gly-X-Y repeats is interrupted by a kink giving rise to a structure resembling a bouquet of tulips (Voss et al., 1988) . SP-D appears as a cruciform structure due to its tetrameric structure (520 kDa) with 4 trimers (Figure 1 ) (Crouch et al., 1994) .
MBL is composed of six 96 kDa trimeric subunits and with bouquet-like structure similar to SP-A due to kink interruption within 19 Gly-X-Y repeats. Unlike other collectins, MBL can activate the lectin pathway of the complement cascade via MBL associated serine proteases (MASPs) (Ji et al., 1997; Thiel et al., 1997; Thiel, 2007; Degn et al., 2012) . MBL2 gene encoding functional human MBL protein has 3 single nucleotide polymorphisms (SNPs) at codon 52 (variant D-alelle, Arg52 Cys), codon 54 (Variant B-allele, Gly54 Asp) and codon 57 (Variant C allele, Gly57 Glu). SNPs within the MBL2 at codon 54 consist of two variants: allele A (wild type) and allele B (Madsen et al, 1994; Madsen et al, 1995) . SP-A, SP-D and MBL have been extensively shown to involved in innate immune anti-microbial defence via a range of mechanisms including modulation of adaptive immunity, and thus, feature centrally in the regulation of inflammation.
Complement component C1q (460 kDa) is the first subcomponent of the complement classical pathway with three polypeptide chains (A, B and C). The A, B and C chains comprise of N terminal domain with cysteine residues, a collagen-like region (CLR), and a C-terminal globular domain (gC1q) (Sellar et al., 1992) . C1q is involved in innate host defence and several modulatory process including pathogen clearance, apoptosis, angiogenesis, chemotaxis, cell differentiation, adhesion, migration, coagulation via platelets, autoimmunity, isotype switching, tolerance (Kishore et al., 2004) .
The human genes for SP-A, SP-D and MBL are located on the long arm of chromosome 10 between 10q21-24 (Crouch et al., 1993) . All three A, B and C chains of human C1q are located on chromosome 1p34.1-1p36.3 (Sellar et al., 1992) (Table 1 ). The ciliated alveolar epithelial type II pneumocytes and non-ciliated bronchial Clara cells in lungs are the major source of SP-A and SP-D (Ballard et al., 1986; Persson et al., 1988) . Unlike most of the collectins largely synthesized by lungs, MBL and C1q are synthesized in the liver (Kawasaki et al., 1978) . However, extra-pulmonary and extra-hepatic biosynthesis of collagens have been reported (Table 2) . Using RT-PCR, expression of SP-A, SP-D, MBL and C1q transcripts have also been shown in salivary glands, lacrymal glands (Madsen et al., 2003) , pancreas, bile ducts, thymus, prostate (Madsen et al., 2000) , colon (Eliakim et al., 1997) , small and large intestine (Uemura et al., 2002) , brain, spleen (Wagner et al., 2003) , Kidney (Ezekowitz et al., 1988) , epithelial cells, mesenchymal cells (Morris et al., 1978) , dendritic cells (Vegh et al., 2003) , microglial cells (Farber et al., 2009) (Table 2 ).
The roles of collectins and C1q are not solely restricted to recognition and elimination of pathogens. Evidence clearly demonstrates that these soluble defence collagens are at the crossroads of both innate and adaptive immunity as they regulate inflammation, hostpathogen interaction, immune tolerance and offer immune protection at multiple levels.
Furthermore, their deficiency and dysregulated expression has been associated with infectious diseases. An intriguing feature of collectins (SP-A, SP-D, and MBL) is that they exhibit dual immunological function (pro-inflammatory and anti-inflammatory) based on their interaction with candidate receptors, SIRP-α and calreticulin/CD91 (Gardai et al., 2003) . Recent studies have highlighted the importance of these soluble proteins in novel functions related to maintenance of pregnancy (implantation, vascular remodeling, and placental formation) and parturition. Here, we discuss collectins and C1q with respect to their cellular sources, their expression in the female reproductive system, and their roles in pregnancy and parturition.
Expression of collectins and C1q in the female reproductive system

Peripheral blood and serum
During pregnancy, no significant changes can be observed in the levels of SP-A in maternal serum before (7-74 ng/ml) or after labor (9.6-73.6 ng/ml) (Cho et al., 1999) . The concentration of serum MBL in various individuals varies depending on the SNPs in the promoter region and the coding region (exon-1) of the MBL-2 gene (Bodamer et al., 2006) .
The structural mutation in exon-1 (encoding a single polypeptide region, a cysteine rich region and a part of collagen region) of the MBL-2 gene has been proposed to impair higher oligomer formation preventing the functional ability of MBL to activate the complement lectin pathway via MASPs (Matsushita et al., 1995; Terai et al., 2003; Roos et al., 2003) . It may be concluded that polymorphisms in the promoter region significantly decrease the serum MBL level, and hence, very little amount of higher oligomeric forms of MBL can be observed in serum when compared to trimeric and tetrameric forms. During pregnancy, MBL genotypes and polymorphisms correlate with the serum concentration of MBL. Hence, serum levels of MBL increase in the first trimester and then decrease in the 6 th week post-partum (van de Geijn et al., 2007a) . In another study, levels of MBL in the peripheral blood remain relatively constant throughout pregnancy in all three trimesters and at delivery, but decreases sharply after delivery (Thevenon et al., 2009) .
C1q levels in normal pregnancies were significantly lower than in non-pregnant women, and levels in spontaneous abortions were significantly higher than in normal pregnancies. Furthermore, it has been shown that artificial and spontaneous abortions can be prevented by treatment, which decreases C1q levels within 7 days (Saitoh et al., 1983) .
Non-pregnant female reproductive tract
Maternal endometrium undergoes cyclic changes regulated by steroid hormones during the menstrual cycle that directs the differentiation of endometrial epithelial and stromal cells crucial for uterine receptivity and implantation for pregnancy (Kannan et al., 2010) . The first direct demonstration of SP-D mRNA and protein expression in the uterus suggested the possible roles and significance of collectins in innate host defense against pathogens (Madsen et al., 2000) . Protein and mRNA expression of SP-A and SP-D have been observed in the female vagina, uterus, ovary, cervix, and oviduct (Table 2, Figure 2 ) (Akiyama et al., 2002; Oberley et al., 2004; Leth-Larsen et al., 2004) . In humans, a strong expression of SP-D in the epithelium of the endometrial glands is observed that increases towards the secretory phase of regular menstrual cycle compared to the proliferative phase (Leth-Larsen et al., 2004) . In mouse uterus, SP-D has shown to be hormonally regulated, with peak levels present at estrus, which then decreases at diestrus (Kay et al., 2015) . Ovariectomised mice showed significantly reduced expression of SP-D in uteri; following treatment with estrogen and progesterone, SP-D expression increased nine-fold (Kay et al, 2015) . Further, treatment with progesterone during diestrus reduced the level of SP-D making them vulnerable to infection (Oberley et al., 2007) .
SP-A is reported to be expressed by both pre-and post-menopausal vaginal stratified squamous epithelium and vaginal lavage fluid (MacNeill et al., 2004) . Using immunohistochemistry, SP-A expression within the glandular and stromal cells has been observed in the maternal endometrium during the early proliferative phase (day 6-7) of the menstrual cycle. The levels of MBL in the vaginal epithelial cells vary in a cycle-dependent manner with greater changes occurring in the secretory phase of the menstrual cycle. This change, which is associated with progesterone, implicates the protective role of MBL in the female genital tract . These findings strongly suggest that cyclic variations in SP-A, SP-D and MBL expression are hormonally regulated.
Amniotic fluid and umbilical cord
Amniotic fluid (AF) is in constant contact with the fetus throughout pregnancy. It protects and supports fetal development (Underwood et al., 2005) . Secretions of soluble immune factors from the fetal lungs travel into the AF (Condon et al., 2004) , which is likely to have anti-microbial functions (Underwood et al., 2005) . SP-A and SP-D are detected in the AF during the mid-pregnancy and their concentrations significantly increases with advancing gestational age reaching maximum at term (ranging between 1.2 and 15 µg/ml) (Miyamura et al., 1994) . SP-D level gradually increases from 0.11 µg/ml (14-16 th week) to 26.3 µg/ml (38-42 nd week). SP-A is highly regulated near term; it shows a clear rise from 3 µg/ml (30-31 st week) to 24 µg/ml (40-41 st week) when compared to SP-D (Miyamura et al., 1994) . At term (39 th week), the levels of SP-A and SP-D reach their maximum 4978 µg/ml and 793 µg/ml, respectively (Miyamura et al., 1994) . Thus, changes in the AF levels of SP-A and SP-D can act as a biomarker to assess fetal maturity (Table 3) . At term, there is at least 2-fold increase in the levels of SP-A in the umbilical cord blood in newborn babies delivered by spontaneous labor between 36 and 38 weeks (4.8-50.2 ng/ml) when compared to those delivered through cesarean section i.e., with no labor (2.7-21.7 ng/ml) (Cho et al., 1999) .
A similar pattern of increase in the AF level for MBL is observed with advancing gestational age ; however, it varies significantly before and after 35 weeks of gestation (304 µg/ml and 1070 µg/ml, respectively) compared to the serum level of MBL (995 µg/ml) (Table 3 ). The C1q level in AF is less than 0.5 µg/ml compared to its level in the plasma (80 µg/ml) (Miyamura et al., 1994) . The level of fetal MBL in the umbilical cord blood (venous and artery 0.70 µg/ml) is low when compared with the maternal peripheral blood before elective cesarean section (1.11 mg/ml) (Kielgast et al., 2003; Oudshoorn et al., 2008) . The gestational age-dependent changes in the AF levels of collectins may have distinct roles at different stages of pregnancy and parturition in addition to a protective role against infection and inflammation.
Pregnant uterus (amnion, chorion, decidua, myometrium and placenta)
SP-A and SP-D are present in the human fetal membranes, amniotic epithelium and chorionic membrane (Han et al., 2007) , the chorio-decidual layer of the late pregnant uterus (Miyamura et al., 1994) , trophoblast of late normal placental villi, early human placenta (Sati et al., 2010) , cytotrophoblast, intermediate trophoblast, and syncytiotrophoblast of early gestation (Miyamura et al., 1994; Leth-Larsen et al., 2004) (Table 2 ; Figure 3 ). Cytotrophoblasts and mesenchymal cells have been shown to express MBL during early pregnancy (Kilpatrick et al., 1995; Yadav et al., 2016) . MBL is synthesized by human term placenta and decidua (Yadav et al, 2014) . Complement-activating natural IgG is found deposited on the placental tissues (Richani et al., 2005; Bulla et al., 2008) . Both early (C1q and C4) and late (C5, C6, C9) complement components are seen in the placenta. C1q is widely distributed around the fetal vessels, spiral arteries, trophoblast, decidual endothelial cells, and extravillous trophoblasts (EVT) (Figure 2 and 3) (Bulla et al., 2008 Agostinis et al., 2010) . We recently showed the expression of SP-A, SP-D and C1q in early human decidua specifically on stromal cells and EVT by immunohistochemistry. Transcripts of A, B and C chains of C1q
were also detected in early human decidual stromal cells (Madhukaran et al., 2015a) . SP-A and SP-D are synthesized by human term and first trimester placental and decidual tissues (Yadav et al, 2014; Yadav et al, 2016) . As the expression of collectins in gestational tissues is established, an underlying role that directs cellular processes and other signaling pathways in pregnancy needs to be examined.
Role of collectins and C1q in early pregnancy
Recently, the expression and localization of SP-A, SP-D and C1q was examined in human decidua within the decidual trophoblast and stromal cells (DSCs) Madhukaran et al., 2015a) . There is evidence to suggest that transcription factor PU.1
regulates the decidual expression of C1q in early pregnancy (Madhukaran et al., 2015b) . This suggests that C1q, regulated by PU.1, may be a critical factor in trophoblast and stromal cell development (differentiation and proliferation) at the feto-maternal interface.
Our preliminary analysis using triple immunofluorescent staining identified trophoblast (verified by intracellular marker cytokeratin 7, CK-7) exhibiting the expression of can have a significant impact on the immunotherapy for adverse pregnancy such as abortion, miscarriage, and preeclampsia (PE) (Madhukaran et al, unpublished) . Our study validates a previous report showing that C1q localizes to the EVT and promotes its invasion, spiral artery remodeling and normal placentation at the feto-maternal interface (Singh et al., 2011) .
Further, the evidence that C1q produced by decidual endothelial cells (DECs) suggests that it acts as a link between the endovascular trophoblasts and spiral artery endothelial cells, involving the MAP kinase pathway via gC1qR, a receptor for the globular head region of C1q (Bulla et al., 2008; Agostinis et al., 2010; Agostinis et al., 2012) .
SP-D levels in the uteri progressively decrease from 0.5 days post coitus (dpc) to 2.5 dpc during early pregnancy, suggesting relevance of uterine SP-D in peri-implantation period in mice (Kay et al, 2015) . SP-D gene deficient mice showed significantly increased preimplantation loss, leading to a considerably reduced litter size (Kay et al, 2016, unpublished) .
During spontaneous abortion, SP-A was significantly downregulated while SP-D was upregulated at the feto-maternal interface (Yadav et al, 2016) .
There 
Collectins and C1q in parturition and complicated pregnancy
Parturition is an inflammatory process and is associated with significant upregulation of SP-A, SP-D and MBL levels in AF, with advancing gestational age (Miyamura et al., 1994) . Any mutations, SNPs, unusual expression or deficiency involving SP-A, SP-D, MBL, or C1q can be associated with pregnancy complications. Multiple etiologies for various pregnancy complications have been described; however, over one-half of the cases remain unexplained.
Although the physiology of pregnancy, initiation and regulation of parturition in human and mice are quite distinct (Bezold et al., 2013) , studies using murine models, deficient or overexpressing genes, have been used to understand the role of SP-A, SP-D, MBL or C1q in pregnancy.
SP-A and SP-D
SP-A, SP-D and MBL level reaches maximum at term in AF, which suggests its association with pregnancy maintenance and parturition. Parturition is marked by local production of numerous factors including pro-inflammatory cytokines and hormones (glucocorticoids and PGF2α) (Myatt and Sun, 2010) . Expression of SP-A in mouse fetal lungs (after 17 dpc) and its secretion in AF provide a signal for initiation of parturition (Condon et al., 2004; Mendelson and Condon, 2005) . Gestational increase in the AF SP-A level augments the production of IL-1β, NF-κB and PGF2α and infiltration of AF macrophages into fetal membrane, myometrium, uterus and cervix, which probably serve as a signal for labor (Condon et al., 2004) . In pregnant mice, intra-amniotic injection of purified SP-A at 15.5 dpc stimulates IL-1β production, leading to preterm delivery within 6-24 hr ( Figure 6 ).
Conversely, injecting anti-SP-A antibodies into the mice amniotic sac can delay parturition by up to 24 hours (Condon et al., 2004) . The view by Condon et al. that fetal SP-A triggers the onset of labor is consistent with our recent finding that SP-A and SP-D levels are low during pre-(17.5dpc) and near (19.5 dpc) parturition in the murine decidua (Madhukaran et al., 2015c) . Despite the elevated SP-A and SP-D levels in the AF at term, the transcript level of decidual (maternal) SP-A was absent. The withdrawal of decidual SP-A might be responsible for controlling the functional activation of fetal-derived SP-A which regulates parturition at term by two different pathways: the endocrine pathway where SP-A in the fetal circulation reaches the placenta and the uterus directly, or with the support of maternal SP-A produced before term. In the paracrine pathway, the fetal lung-derived SP-A enters the AF to exert its effect by increasing AF concentration (26 th week to 32 nd week) on the fetal membrane (amnion and chorion) to transmit the signal to the myometrium and cervix for the initiation of labor. A better understanding of the role of the fetal SP-A in signalling parturition is required to define the association of fetal and maternal SP-A in parturition. This will also enable us to recognize and prevent the inflammatory responses stimulated in various pregnancy complications
In contrast, SP-D levels were found to decrease with the gestation age from 17.5 dpc to 19.5 dpc in murine decidua (Madhukaran et al., 2015c) . We suspect that increased SP-D level at 17.5 dpc could reflect paracrine effect on fetal membrane, cervix and myometrium involved in hindering prostaglandin E2 activation required for labor. The subsequent decrease in SP-D at 19.5 dpc might be functional withdrawal of SP-D prerequisite for upregulation of PGE2, cyclo-oxygenase enzyme-2 (COX2) and increased myometrial sensitivity to estrogen in association with labor process. Altogether, SP-A and SP-D in decidua indirectly regulate parturition. We also demonstrated the host defense role for SP-A and SP-D in the decidua at term, which has the ability to inhibit the release of TNF-α upon LPS challenge, as an indicator of intrauterine infection preventing preterm labor and birth (Madhukaran et al., 2015c) .
Before labor, decidual SP-A is highly expressed when compared to the levels in those with labor. Surprisingly, SP-A-induced (100 µg/ml) pro-inflammatory soluble factors (IL-6, IL-8, TNF-α, IL-1β, MCP-1, MMP-3 and VEGF) did not exhibit any significant difference in stromal cells (Snegovskikh et al., 2011) . Additionally, detailed investigation of prostaglandin (PGF2α) production revealed that the presence of SP-A in the endometrium selectively inhibits PGF2α production, suggesting that endometrial SP-A expression may specifically regulate prostaglandins during labor (Snegovskikh et al., 2011) . In human myometrial cells, SP-A from the fetal membrane induces actin stress fibre formation by controlling F-actin filament organization, suggesting that SP-A regulates the initiation and maintenance of uterine contraction (of smooth muscle cells) for labor (Garcia-Verdugo et al., 2008; BreuillerFouché et al., 2010; Sotiriadis et al., 2015) .
Despite strong indications that SP-A is an important signal linked with parturition, little is known about the underlying molecular events. Moreover, fetal macrophages were not found in the maternal tissue (myometrium) at term (Kim et al., 2006) and SP-A gene-deficient mice were able to go into spontaneous labor (Korfhagen et al., 1998; Montalbano et al., 2013) . Subsequent studies proved SP-A to be anti-inflammatory ( Figure 6 ). In vitro interaction of AF SP-A with human placental amnion has been proposed to down-regulate the expression of IL-1β, CXCL2 and CXCL5, a mechanism essential for initiation of parturition (Lee et al., 2010) . Injection of SP-A into the extra-amniotic space within the uterus exposed the anti-inflammatory role of fetal lung SP-A with downregulated expression of inflammatory molecules (IL-1β, TNF-α, NF-κB and CCL5) via TLR2 in the placenta and fetal tissues. Simultaneously, SP-A was shown to enhance the expression of antiinflammatory molecules (CXCL1 and IL-10) within the placental, fetal and uterine tissues that can prolong the gestation (Agrawal et al., 2013) . A recent study has examined inflammatory and contractile genes from mice deficient in SP-A or SP-D. Prolonged gestation was observed for ~10-12 hrs in SP-A deficient mice (2 nd and 3 rd litter) with reduced levels of IL-1α, IL-1β and IL-6 in the myometrium compared to the wild-type mice.
Furthermore, the expression of contractile genes (oxytocin receptor and connexin-43) was not significantly higher than control delaying parturition (Montalbano et al., 2013) . Induction of oxytocin receptor (OXTR) and connexin 43 (CX43) expression and secretion of GROα (chemokine CXCL1) and IL-8 by the myometrial cell line, ULTR, following treatment with SP-A and SP-D provides further evidence that the two collectins play a key role in modulating events prior to labour by reconditioning the human myometrium and thus shifting the uterus from a quiescent to a contractile state (Sotiriadis et al., 2015) .
The association of transcription factor, Forkhead box M1 (FOXM1), with lung maturity and expression of SP-A has been examined in an animal study. FOXM1 was utilized for studying the fetal lung development due to its regulatory functions related to cellular proliferation, differentiation, vascular remodelling and metabolism. The study found that as FOXM1 (mRNA and protein) expression increased, SP-A (mRNA) expression decreased in rabbit fetal lungs (Hahn et al., 2013) . A significant delay in parturition of nearly 38 hrs has been recently reported in steroid receptor coactivators 1 and 2 (SRC-1 and SRC-2) doubledeficient mice with reduced expression of NF-κB, PGF2α, and contractile genes (oxytocin receptor, connexion-43, cyclooxygenase 2, prostaglandin-endoperoxide synthase 2), SP-A, lysophosphatidylcholine acyltransfereae-1 (LPCAT-1), pro-inflammatory glycerophospholipid and platelet-activating factor (PAF) in near term fetal lungs, maternal myometrium and in fetal AF (Gao et al., 2015) . Exogenous injection of SP-A (3 µg/sac) or PAF (0.25 ng/sac) into the amnion of SRC-1/2-deficient mice at 17.5 dpc activated the downstream signals in parturition cascade by enhancing NF-κB and contractile genes. SP-A or PAF injection lowered both steroidogenic acute regulatory protein (StAR) and P4 in circulation (Gao et al., 2015) . This correlation between SRC-1/2 and SP-A or PAF expression highlights fetus signal in parturition. Therefore, maturation of fetal lungs and SP-A secreted from lungs may be used as a potential marker for forecasting lung maturity and survival of the fetus by generating a signal to initiate labour at term. The importance of SP-D in parturition has also been shown by the finding that methionine allele SP-D gene polymorphism (methionine allele, Met31Thr) in the fetus is associated with spontaneous preterm birth within the Northern Finland population (Karjalainen et al., 2012) .
Since SP-A serves as a key signal molecule for initiation of parturition, levels of AF SP-A at term in labor (spontaneous human parturition) and without labor have been measured. AF SP-A level was shown to decrease (1.2-10.1 µg/ml) in spontaneous labor at term when compared to women not in labor (2.2-15.2 µg/ml) (Chaiworapongsa et al., 2008b) .
However, an insignificant difference in the levels of SP-A was observed in maternal serum before and after labor (Cho et al., 1999) . The biological significance of placental SP-A, SP-D and MBL in parturition is further supported by the altered levels of SP-A, SP-D and MBL in spontaneous term labor (Yadav et al., 2014) . Another study using SP-A or SP-D overexpressing mice has shown that maternal challenge with an increasing concentration of LPS (intraperitoneal injection of smooth LPS) from 17 dpc till term (12 µg, 15µg, 20µg and 25 µg/mouse) modulates the LPS-induced cytokine response within the mother and the fetus inducing spontaneous preterm labor ( Figure 6 ). Increased expression of TNF-α and IL-10 in AF and fetal membrane was detected when compared to the wild type controls (Salminen et al., 2008 (Salminen et al., , 2011 (Salminen et al., , 2012 . Thus, higher SP-A or SP-D concentrations do not correlate with the timing of labor, but instead, they increase the risk of preterm birth and fetal mortality. It is likely that an increase in maternal SP-A or SP-D levels during infection induced preterm labor can be a useful marker to predict the outcome of pregnancy, though it would require extensively planned, large clinical studies.
MBL
Very little is known about the role of MBL in parturition. Due to the increase in the level of MBL in first trimester till term with sharp decrease after delivery, MBL is believed to be involved in the parturition process and onset of labor. MBL-2 gene polymorphism has been reported to affect the immunological events in normal pregnancy. The presence of MBL-2 gene polymorphism is beneficial at times but not in all cases, as it is also associated with complicated pregnancies. In immunocompromised women with genetic polymorphisms and low levels or deficiency of MBL during mid-pregnancy are related to functional changes in the placenta; in particular, placental lesions, placental insufficiency, and inflammatory infiltrates are associated with low gestational age and low birth weight (van de Geijn et al., 2008) , recurrent abortions, idiopathic recurrent late pregnancy loss (Christiansen et al., 2009) , unexplained recurrent miscarriages Kruse et al., 2002), chorioamnionitis, and PE (van de Geijn et al., 2007b; Holmberg et al., 2008) . There is also an increased expression of MBL in uterine lumen during oocyte collection in patients with unexplained infertility when compared to tube infertility patients (Oger et al., 2009 ).
Bodamer et al. have examined polymorphisms in the coding and promoter regions of MBL-2 in premature infants. In particular, codon 52 was demonstrated to have a significant association with the group of infants born preterm (before 36 weeks) compared with the infants born at term (Bodamer et al., 2006) . In a correlation study between MBL levels and recurrent miscarriage, a low level of serum MBL (0.1 mg/ml) was observed in blood samples obtained from both male and female partners with recurrent miscarriage (Kilpatrick et al., 1996 . Furthermore, decreased MBL levels at the feto-maternal interface have been reported to be insufficient to regulate infection-induced inflammatory response leading to fetal loss (Kilpatrick et al., 1995) . Taken (Madsen et al., 1995 (Madsen et al., , 1998 The gene polymorphisms of MBL-2 gene in the structural region as well as promoter region that contribute to low levels of MBL showed a significant association with the pathogenesis of PE in Brazilian women (Vianna et al., 2010) . Maternal MBL-2 genotype (variant B allele, codon 54) is implicated in a protective role against the development of PE and PE-associated intrauterine growth restriction (IUGR) via complement activation ( Figure   7 ). The frequency of MBL-2 gene polymorphism compared between women with PE and full term controls were examined. Importantly, higher MBL-2 genotype levels were detected in PE women (~86-95%) compared to full-term controls (~70-83%) (Sziller et al., 2007a) .
Excessive lectin pathway activation and an increase in placental MBL levels are likely to impair trophoblast invasion and spiral arteries formation, resulting in activation of hypoxic signaling pathway related to PE (Girardi et al., 2006) . With an increase in maternal MBL-2 genotype activity, their ability to activate complement is affected, as low serum MBL levels are unable to interact with MASPs, thus protecting the placenta against development of PE.
Maternal variant A (wild type allele) in codon 54 of MBL2 has been proposed to increase MBL levels in serum that is associated with the development of PE (Figure 7) . Recently, Agostinis and colleagues implicated MBL as a major protein found to be increased in the sera obtained from PE patients, which is potentially responsible for inhibiting the cell communication between fetal trophoblasts and decidual endothelial cells preventing trophoblast invasion . This is consistent with the findings in earlier studies in which C1q expressed by decidual cells (endothelial cells and trophoblasts) was shown to enhance the cross-talk between fetal trophoblasts and decidual endothelial cells essential for trophoblast migration and invasion, spiral artery formation, vascular remodeling and placental development (Bulla et al., 2008; Agostinis et al., 2010) . The best evidence for protective role of MBL has come from studies of abortion-prone mouse model (CBA/J X DBA/2) of PE. MBL-A has been detected at the early stages of pregnancy (3.5dpc) while MBL-A deficiency demonstrated to prevent pregnancy loss. Furthermore, DBA/2-mated CBA/J mice were able to prevent fetal loss efficiently after polyman2 (mannosylated molecule that binds to MBL-A with high affinity) treatment (Petitbarat et al, 2015) . Thus, increased levels of MBL in PE may contribute to the failure of the endovascular invasion of trophoblast cells.
In another study, however, no systematic functional activity of MBL-MASP2 levels were found to correlate with the disease onset, severity, fetal growth restriction, or birth weight linked to PE (Csuka et al., 2010) . The study classified PE and normal pregnant participants into three groups, namely MBL deficient, MBL normal and MBL high.
Importantly, complement activation was relatively higher in both MBL high as well as MBL deficient categories. It is speculated that altered (both low and high) levels of MBL can give rise to dysregulated complement activation, thus contributing to PE (Csuka et al., 2010) . This may explain why some of the studies did not find a significant association of PE with MBL levels. It is likely that deficiency or low levels of MBL in pregnancy probably lead to accumulation of apoptotic cell debris, excessive inflammatory responses, and an enhanced production of autoantibodies, resulting in adverse pregnancy outcomes. In the case of IUGR neonates at birth, the concentration of MBL level in the cord blood remains significantly low, confirming that altered levels of MBL contribute to adverse pregnancies (Briana et al., 2012) .
Given that IUGR neonates are more susceptible to infections, MBL's role in host defense in these neonates is easy to understand. Therefore, altered serum MBL levels can be useful as a biomarker for spontaneous abortion, PE and IUGR.
C1q
C1q deficiency is associated with improper placental formation, trophoblast invasion, impaired angiogenic balance and an increased risk of fetal death resulting in miscarriages, preterm delivery, and PE Singh et al., 2011) . Lower concentration of anti-C1q antibodies and higher levels of IL-15 have been observed in ectopic pregnancies and missed abortions when compared to complicated pregnancies (Daponte et al., 2013) . Storelli et al. have reported that mothers exposed to polychlorinated biphenyls (PCBs) are at a higher risk of spontaneous miscarriage, stillbirth and fetal resorption (Storelli et al., 2011) . Decidual levels of gC1qR correlate with enhanced PCBs content in plasma in mothers who underwent spontaneous abortion (Gu et al., 2012) . Reduced percentage of apoptotic cells were observed in human trophoblast cell line treated with PCBs compared with cells treated with PCBs and gC1qR small interfering RNA (Gu et al., 2012) . This upregulation of gC1qR may have evolved as a defense mechanism to reduce damage to the human trophoblast cells exposed to PCBs resulting in complicated pregnancies.
Villitis of unknown etiology (VUE) is a complication of pregnancy characterized by
inflammation in the chorionic villi. It can be caused by either maternal infection or when placental tissues are affected by immune system i.e. NK cell attack via cytotoxic T cells (Tamblyn et al., 2013) . Distribution of C1q has been observed in the placenta with VUE and within the stroma of inflamed villi suggesting an important contribution of C1q in Villitis (Altemani et al., 1992) .
Human placentae (20 normal and 20 PE) were studied by immunofluorescence for the presence of complement components; C1q was increased in PE as compared to normal tissues (Sinha et al, 1984) . C1q knock-out mice are known to show a defect in the clearance of apoptotic cells and developed glomerulonephritis (Botto et al, 1998) . This study hinted that C1q deficiency might be responsible for accumulation of apoptotic trophoblasts in the pathogenesis of PE. An association of the absence or low levels of C1q in PE patients was recently shown . Subsequent studies confirmed that C1q deficient mice develop symptoms similar to PE; these features include hypertension, albuminuria, endotheliosis, decreased placental VEGF, increased soluble VEGF receptor 1 (sFlt-1), increased oxidative stress, decreased blood flow, increased fetal death, diminished litter size, abnormal invasion of trophoblasts, and increased levels of STAT-8 (inhibitor of trophoblast migration) (Singh et al., 2011) . However, in one of the studies, C1q mRNA expression at placenta was not different between PE women and normal controls (Burma et al, 2012) .
Syncytiotrophoblast microvesicles (STBM) are pro-inflammatory and circulate in increased amounts in PE women and C1q was observed to be one of the 538 proteins unique to PE STBM (Tanetta et al, 2012) . Interestingly, a recent study was able to relate C1q deposits that occur in early onset of PE placenta, with immune tolerance and clearance of apoptotic cells.
The authors have observed more C1q deposition in endothelial stroma, large villi and fibrinoid necrotic areas in the placenta of early onset than in late onset PE women.
Additionally, C1q deposit areas had C4bp protein binding to apoptotic fragments and trophoblastic syncytium knots (Lokki et al., 2014) . These data suggest that C1q, with C4bp
factor released from placenta, may be responsible for immune tolerance by promoting clearance and phagocytic uptake of apoptotic trophoblast cells accumulated in the PE placenta. Association of both low and high C1q levels with PE suggests that any dysregulation in C1q levels may lead to anomalous placental development. .
It is evident now that SP-A, SP-D, MBL and C1q have a regulatory role in pregnancy maintenance and parturition. However, there is yet a lack of clarity on the underlying mechanisms and roles of these proteins in different phases of pregnancy. Once we have this understanding, it may help devise strategies to ameliorate or prevent adverse pregnancy outcomes. Overall, the studies suggest that the regulation of inflammation at the fetomaternal interface is critical, and these molecules, under hormonal influence, are integral to regulation of inflammation. SP-A has the ability to elicit inhibitory or stimulatory response favouring pregnancy maintenance and stimulating parturition driven by maternal or fetal demand, depending on the gestational tissues, receptors and tissue-specific cells. It is difficult to generalize the role of SP-A as an initiator of parturition/contraction due to inconsistency and significant gaps reported so far. However, observational inconsistencies could be due to different endocrine control of parturition in mouse and humans; besides, SP-A could be multifunctional. The underlying mechanism by which fetal or maternal SP-A triggers parturition, evidence for migration of fetal lung specific macrophages into the maternal compartment at term, how these regulatory proteins maintain pregnancy till term although delivery and from those without chorioamnionitis preterm delivery. However, the level of SP-A was increased at term in women with chorioamnionitis compared to spontaneous labor at term (Han et al., 2007) . The comparative analysis of AF SP-A and SP-D levels examined in women with and without IAI showed no significant differences between the SP-A/SP-D and IAI infection in the AF (Chaiworapongsa et al., 2008b) . Conversely, an excessive increase in SP-A due to maternal infection (bacterial) at term pregnancy has been shown to have a negative effect on pregnancy triggering labor. In animal models, intra-peritoneal administration of LPS on 16-17 th day of gestation induces SP-A, but not SP-D, secretion in the uterus at term pregnancy, and initiates parturition (Salminen et al., 2011 (Salminen et al., , 2012 .
Chlamydia trachomatis infection in the female reproductive tract leads to fallopian tube damage and infertility (Paavonen and Eggert-Kruse, 1999) . It has been shown that SP-D, but not SP-A, can inhibit Chlamydia trachomatis infection in a dose dependent manner in the endocervical epithelial cell line (Oberley et al., 2004 (Oberley et al., , 2007 . Additionally, SP-A is also attributed to neonatal immunity. Initially, SP-A knock-out mice were found to be more susceptible to LPS induced inflammatory response with high rate of fetal mortality compared to wild type mice. This inflammatory response was reconciled with oral administration of SP-A which increased the survival of the fetus (George et al., 2008) . In addition, exogenous administration of SP-A or SP-D has also been shown to inhibit LPS mediated TNF-α via decidual macrophages at 17.5 dpc. Thus, decidual SP-A and SP-D appear to offer protection against intrauterine infection towards the term (Madhukaran et al., 2015c) . The molecular mechanism by which the inflammatory condition is modulated is not understood fully.
MBL
Bacterial vaginosis and vulvovaginal candidiasis infection are the most common threat during pregnancy. During early stages of menstrual cycle, there is a significant change in the vaginal microbial flora within the cervico-vaginal cavity (Romero et al., 2014) . MBL, produced by the vaginal cells, are detected in the vaginal lavage along with other normal microflora . The polymorphism in MBL2 gene (condon 54) on exon 1 leads to unstable polymeric MBL proteins that are rapidly degraded (Babovic-Vuksanovic et al., 1999) .
Carriers of this allele have reduced levels of MBL in their circulation and in their vaginal fluid, making them more susceptible to recurrent vulvovaginal candida infection (Babula et al., 2003) . Women with Chlamydia trachomatis infection with variant allele A or B at codon 54 in MBL-2 gene are at a greater risk for fallopian tube occlusion than wild type allele A (Sziller et al., 2007b) . Low levels of MBL are common in patients with tubal factor infertility, sepsis, and septic shock. However, there seems to be no association between MBL deficient genotype and tubal factor infertility (Laisk et al., 2010 (Laisk et al., , 2011 Wahab Mohamed and Saeed, 2012) . Low serum MBL levels can be used as markers for septic shock in mothers and to evaluate the clinical outcome in neonates. MBL-2 gene polymorphism (codon 54, allele B) in the lower genital tract could serve as a marker for predicting Chlamydia trachomatis infection associated with higher risk of fallopian tube damage and early pregnancy loss.
Viral infections such as HBV and CMV, and N. gonorrheae get transmitted from mother to the fetus. These pathogens infect the reproductive tissues such as placenta and chorioamniotic membrane. MBL, an acute phase reactant, is found to be increased in serum after viral infection (Hakozaki et al., 2002) . In human pregnancy, maternal HBV promotes increase in fetal MBL, which probably reflects the protective role of MBL in inhibiting intrauterine infection transmission of HBV from the mother to fetus (Wu et al., 2013) . Low serum levels of MBL with gene polymorphisms at codon 52 (exon I) and codon 54 (allele B)
have been associated with disease progression and poor prognosis of HBV (Thio et al., 2005) .
In contrast, a high serum level of MBL is linked to patient survival with HBV infection (Hakozaki et al., 2002) . Although MBL and HBV have been extensively investigated in human pregnancy, the association of MBL polymorphism with prognosis of HBV infection remains controversial. A study by Hohler et al. was unable to establish a connection between MBL polymorphisms and susceptibility to HBV infection (Hohler et al., 1998) . Similarly, a recent study on SNPs (rs2120131, rs4935047, and rs7095891) in the MBL-2 gene in the Chinese Han population found no association with the susceptibility to HBV (Zhang et al., 2013) . Prenatal and perinatal neonates from CMV infected mother with MBL-2 gene polymorphism when compared with non-infected mothers did not show any increase in the susceptibility of CMV infection (Szala et al., 2011) . The conflicting results may be due to patient recruitment (age, race, origin and previous history), different methodology, control samples, comparison studies, limiting within specific population, sample collected during different periods of pregnancy, and sample size. Further studies are needed to clarify the potential impact of MBL-2 polymorphism in intrauterine infection.
There is ample evidence to suggest that Plasmodium falciparum infection plays an important role in pregnancy outcomes. For instances, P. falciparum-infected erythrocytes membrane protein-1 (PfEMP1) that has affinity for chondroitin sulfate A were observed to infect the red blood cells by residing in the endothelium lining the intervillous space within the placenta. Additionally, they up-regulate infiltration of inflammatory cells and cytokines response via antigen presenting cells leading to massive chronic intervillositis (MCI), IUGR and premature labor (Fried and Duffy, 1996) . Although MBL has been reported to recognize and interact with P. falciparum-infected erythrocytes (Garred et al., 2003) , MBL-2 polymorphism at codon 57 in exon 1 showed no association with placental malaria infection with the concentration of MBL or MBL-2 genotypes measured in the intervillous space (Thevenon et al., 2009) . MBL could opsonize P. falciparum to eliminate the infection through excessive complement activation (Silver et al., 2010) in placental malaria but simultaneously damage the normal placental function (tissue integrity, endothelial activation, vascular remodelling) (Silver et al., 2010) . This excess complement activation may alter the pathogenesis of placental malaria leading to tissue hypoxia, enhanced vascular permeability, and improper placental vasculature contributing to adverse pregnancy outcomes.
Furthermore, binding of MASP-2 with R439H mutation to MBL also reduces the enzymatic activity due to excessive complement activation (Thiel et al., 2009) . This aberrant mutation observed in MASP-2 influences alteration in MBL-2:MASP-2 complex and complement activation (Holmberg et al., 2008 (Holmberg et al., , 2012 . Thus, the modulatory role of MBL, MASPS-2 and downstream complement activation may suggest MASP-2 for therapeutic purpose. Further studies exploring the effects of MBL and MAS-P2 mutations on placental malaria are needed.
C1q
Intraperitoneal injection of serum resistant N. gonorrhoeae pre-incubated with C1q shows a progressive increase in the infection (6-7 days) in an animal model of gonococcal bacteremia in rat pups (Nowicki et al., 1995) . C1q is considered to be involved in clearance of apoptotic debris caused by infection during early pregnancy due to its presence at the feto-maternal interface in decidual endothelial cells (DEC) and trophoblast (Bulla et al., 2008) in normal pregnancy and PE (Lokki et al., 2014) . Besides C1q, expression of MYD88, MD2, and TLR-4 on DEC also contributes to an anti-inflammatory response at the feto-maternal interface . This makes C1q an attractive host defence molecule at the feto-maternal interface. Pathogens like Trypanosoma cruzi spread to humans by blood sucking bug
Triatominae. It can also infect the decidua (trans-placental) by entering the mother through placenta and chorioamniotic membrane (Shippey et al, 2005) . Once T. cruzi is in contact with the host, T. cruzi calreticulin protein (TcCRT; 45 kDa) moves from the endoplasmic reticulum to the external surface of the parasite. Maternal C1q in the placenta recognizes and binds to CRT entering the host (Ramos et al., 1991) . This CRT-C1q interaction prevents the activation of the classical pathway and enhances the spreading of T. cruzi infection (Ferreria et al., 2004; Molina et al., 2005) . Thus, C1q has both a protective role as well as detrimental effect in controlling intrauterine infection.
Collectins and C1q in maternal autoimmune disorders
The most common maternal autoimmune diseases found during pregnancy are autoimmune thyroid disease (AITD), gestational diabetes mellitus (GDM) and rheumatoid arthritis (RA) that cause adverse pregnancy outcomes (Stagnaro-Green et al., 2011) .
Autoimmune thyroid disease (AITD) or autoimmune thyroiditis
Autoimmune thyroid disease is characterized by the stimulation of thyroid glands to secrete more thyroid hormones. The stimulation is due to specific thyroid autoantibodies, thyroid peroxidase (TPO) antibodies (Smallridge et al., 2000) . Generally, the presence of maternal TPO antibodies results in neurophysiological dysfunction at the early stages ( Pop et al., 1995) . In a study of pregnant women, serum MBL level was lower during first trimester and decreased further after delivery in thyroid dysfunction women than in normal controls. On the other hand, women who reported to have an increased serum MBL level during first trimester had significantly decreased MBL levels after delivery (Potlukova et al., 2013) . It is known that thyroid dysfunction influences the MBL level during pregnancy; consequently the association of MBL deficiency with thyroid dysfunction and the outcome of pregnancy have not yet been explained.
Gestational diabetes mellitus (GDM)
The primary cause for GDM is the glucose intolerance during pregnancy mainly due to pancreatic β-cell damage. Tissue damage is caused by the autoantibodies against β-cell of the pancreas. MBL level in both diabetic and healthy women during pregnancy are decreased (Pertyńska et al., 2001) . Subsequent study by same group showed no significant increase in MBL levels in diabetics and healthy pregnant women. But later, statistically significant differences in MBL levels between early and late trimesters in diabetics and healthy pregnant women were observed (Pertyńska et al., 2009) . Women with low plasma MBL level and gene polymorphism in MBL2 (G54D) gene have higher risk of developing GDM in second or third trimesters of pregnancy when compared to R52C mutation (Megia et al., 2004 
Rheumatoid arthritis (RA)
It is a chronic systemic disease of the joints characterized by the inflammatory changes in the synovial membrane, articular structures and atrophy of bones. During pregnancy, MBL recognizes/binds to agalactosyl IgG and activates the complement system. By doing so it clears the autoantibodies (IgG) and recruitment of inflammatory cells associated with RA.
Thus, the level of agalactosyl IgG is decreased while galactosylation is believed to improve pregnancy associated RA disease condition (van de Gejin et al., 2009) . Postpartum decrease in IgG galactosylation and MBL leads to outburst of RA disease (Malhotra et al., 1995) . The study by van de Gejin et al. provided further evidence of the dual function of MBL in pregnancy; firstly, on the role of MBL-2 clearing the pathogenic agalactosyl IgG, and secondly, its link with the pathogenesis of RA. Despite their relevance in defence mechanism, MBL genotype has no association with RA disease activity or modification of IgG galactosylation during pregnancy and after delivery (van de Gejin et al., 2011) . The studies described above outline the delicate role of MBL exerted during pregnancy-associated autoimmune diseases. Their role possibly differs depending on the polymorphism and the type of autoimmune disease.
Conclusion
Collectins and C1q are implicated in the immune-cross talk at the feto-maternal interface.
Although they appear to increase progressively in the gestational tissues with advancing gestational age, their overall role in pregnancy maintenance and parturition, specific functions at different gestational age is not yet clear in normal and abnormal pregnancy.
However, due to their ability to exhibit dual role (protective and detrimental), assigning specific role for each protein in pregnancy is difficult. Hence, further investigations are required to understand the direct cellular and regulatory roles played by collectins and C1q in normal pregnancy. Moreover, events in pregnancy are species-specific; the availability of animal models (gene deficient or over expressing) will enable to gain further insight into the Such studies will help us generate new hypothesis to identify key mechanism inducing immunotolerance. Evaluating the biological significance of C-type lectins in uterine/myometrial contraction, and cervical ripening that triggers contraction will provide us great opportunity to develop therapeutic strategies for adverse pregnancies. (A) Expression of SP-A1, SP-A2, SP-D, C1q A, C1q B, and C1q C in human decidua obtained from women undergoing elective termination of pregnancy during first trimester. 7+6: 7 weeks and 6 days of gestation; 8+2 : Average of 5 samples of 8 weeks and 2 days of gestation; 8+6: 8 weeks and 6 days of gestation; 9+0: Average of 2 samples of 9 weeks of gestation; 9+2: 9 weeks and 2 days of gestation; 9+5: 9 weeks and 5 days of gestation; 10+3: 10 weeks and 3 days of gestation.
(B) Expression of SP-A1, SP-A2, SP-D, C1q A, C1q B, and C1q C in human decidua obtained from women undergoing elective termination of pregnancy during first trimester and from women undergoing labor with a previous history of miscarriages. 8+4 (8 weeks and 4 days of gestation) with 1 previous miscarriage, 9+4 (9 weeks and 4 days of gestation) with RPL with 4 previous miscarriages; 39+1 (39 weeks and 1 day of gestation) had RPL with 2 previous miscarriages; Caesarean section (CS) with 2 previous miscarriages; lower segment caesarean section (LSCS) with 2 previous miscarriages. Figure 5B : Madhukaran et al 
